Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMA5 pseudogene 1 (PSMA5P1) is annotated as a pseudogene related to PSMA5, which means it is generally a non-coding DNA fragment resembling the protein-coding gene PSMA5. There is no evidence of it encoding a functional protein or serving as a therapeutic or pharmacological target. The protein-coding parent gene, PSMA5 (proteasome subunit alpha type-5), is an essential component of the 20S proteasome complex, responsible for the regulated degradation of most intracellular proteins as part of the ubiquitin-proteasome system[1][3][4][5][6]. Dysfunction in proteasome activity (including its subunits) is associated with diseases such as cancers, neurodegenerative disorders, and autoimmune conditions, and is a target of several cancer drugs. However, no such functional or therapeutic relevance is attributed to PSMA5P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PSMA5 pseudogene 1 (PSMA5P1).